Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRADA FOR INFANT URINE COLLECTION DEVICE

This article was originally published in The Gray Sheet

Executive Summary

CRADA FOR INFANT URINE COLLECTION DEVICE being sought by the Centers for Disease Control and Prevention, according to a June 23 Federal Register notice. The agency is seeking a participant for a Cooperative Research and Development Agreement "to develop innovative ways for collecting urine from infants for subsequent analysis for the presence of viruses." The goal of the CRADA is "to develop a screening test which would be less time consuming and more cost effective for determining whether an infant is infected with cytomegalovirus [CMV] or other specified viral infection," CDC says. Under the CRADA, CDC will be responsible for developing a diagnostic test, while the collaborator "will specially design a new diaper or diaper insert that would enable a diagnostic strip to be placed in it." Explaining the need for the invention, CDC says that while infant viral infections can be detected in urine, the current method for collecting urine -- "placing a urine bag on an infant" - - is "a time-consuming and expensive procedure." Inventions arising from the CRADA are likely to be licensed on a royalty-bearing basis to the collaborator, CDC notes. Potential collaborators are given 30 days from the notice's publication date to respond.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel